This document is an excerpt from the EUR-Lex website
Document 62022TO0416
Order of the President of the General Court of 18 October 2022.#Fresenius Kabi Austria GmbH and Others v European Commission.#Interim relief – Medicinal products for human use – Directive 2001/83/EC – Marketing authorisations for medicinal products containing the active substance ‘hydroxyethyl starch (HES), solutions for infusion’ – Application for suspension of operation of a measure – No urgency.#Case T-416/22 R.
Order of the President of the General Court of 18 October 2022.
Fresenius Kabi Austria GmbH and Others v European Commission.
Interim relief – Medicinal products for human use – Directive 2001/83/EC – Marketing authorisations for medicinal products containing the active substance ‘hydroxyethyl starch (HES), solutions for infusion’ – Application for suspension of operation of a measure – No urgency.
Case T-416/22 R.
Order of the President of the General Court of 18 October 2022.
Fresenius Kabi Austria GmbH and Others v European Commission.
Interim relief – Medicinal products for human use – Directive 2001/83/EC – Marketing authorisations for medicinal products containing the active substance ‘hydroxyethyl starch (HES), solutions for infusion’ – Application for suspension of operation of a measure – No urgency.
Case T-416/22 R.
ECLI identifier: ECLI:EU:T:2022:636